Vestal Point Capital, LP Applied Therapeutics Inc. Transaction History
Vestal Point Capital, LP
- $1.69 Trillion
- Q4 2024
A detailed history of Vestal Point Capital, LP transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Vestal Point Capital, LP holds 11,500,000 shares of APLT stock, worth $6.1 Million. This represents 0.58% of its overall portfolio holdings.
Number of Shares
11,500,000
Previous 1,145,000
904.37%
Holding current value
$6.1 Million
Previous $9.73 Billion
1.17%
% of portfolio
0.58%
Previous 0.74%
Shares
5 transactions
Others Institutions Holding APLT
# of Institutions
130Shares Held
112MCall Options Held
1.1MPut Options Held
800K-
Vr Adviser, LLC New York, NY9.99MShares$5.3 Million1.4% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA9.62MShares$5.1 Million8.18% of portfolio
-
Morgan Stanley New York, NY8.82MShares$4.67 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY8.76MShares$4.64 Million0.05% of portfolio
-
Black Rock Inc. New York, NY6.57MShares$3.48 Million0.0% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $25.5M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...